Hemagen Diagnostics (HMGN) Stock Price & Analysis
HMGN Stock Chart & Stats
- Day’s Range
- $0.02 - $0.02
- 52-Week Range
- $0.02 - $0.04
- Previous Close
- $0.02
- Volume
- 100
- Average Volume (3M)
- 0
- Market Cap
- $3,100
- Enterprise Value
- N/A
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- 2337.97
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
HMGN FAQ
What was Hemagen Diagnostics’s price range in the past 12 months?
What is Hemagen Diagnostics’s market cap?
When is Hemagen Diagnostics’s upcoming earnings report date?
Is Hemagen Diagnostics overvalued?
Does Hemagen Diagnostics pay dividends?
What is Hemagen Diagnostics’s EPS estimate?
How many shares outstanding does Hemagen Diagnostics have?
Which hedge fund is a major shareholder of Hemagen Diagnostics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Hemagen Diagnostics
Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- William Hales
- Employees
- 15
- Website
- www.hemagen.com
- Address
- 9033 Red Branch Road, Columbia, MD, 21045, US
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 1 | 9 |
| Technical Analysis | 2 | 1 | 2 |
| Moving Averages | 1 | 0 | 7 |